11 resultater
FIELD OF THE INVENTION
The present invention relates to a method of treatment of movement disorders, comprising administering to a patient in need thereof an effective amount of befiradol, wherein the administering step provides an average patient's maximum plasma concentration of befiradol below
The invention relates to tetrahydropyridinyldibenzazepine derivatives of formula I ##STR2## wherein R.sub.1 is a substituent selected from the group consisting of hydrogen, halogen, and lower alkyl;
R.sub.2 is selected from hydrogen, and unsubstituted or hydroxy substituted lower alkyl or lower
BACKGROUND OF THE INVENTION
Morphine or other bimodally-acting opioid agonists are administered to relieve severe pain due to the fact that they have analgesic effects mediated by their activation of inhibitory opioid receptors on nociceptive neurons (see North, Trends Neurosci., Vol. 9, pp. 114-117
BACKGROUND OF THE INVENTION
A method for the treatment of acne vulgaris as disclosed in U.S. Pat. No. 4,005,198, by the inventor herein which is herein incorporated by reference, is the bi-daily oral administration of methyclothiazide, optionally with the daily concurrent administration of
FIELD OF THE INVENTION
This invention relates to a composition that taken as recommended will substantially reduce the deleterious effects of alcohol on the body and substantially reduce the side-effects associated with hangovers (i.e. headaches, dizziness, nausea, dry mouth, etc).
BACKGROUND OF THE
FIELD OF THE INVENTION
The present invention relates to a "stewardess" composition suitable for the prevention of disadvantageous physiological symptoms occurring during unusual external movement (such as transportation) of healthy humans and mammal animals containing a compound of the general
FIELD OF THE INVENTION
This invention relates to new therapeutic uses of tramadol and its structural and/or functional analogues, and to new formulations thereof.
BACKGROUND OF THE INVENTION
Tramadol has the chemical name (+/-)-trans (RR,SS)-2-[(di-methylamino)methyl]-1-(3-methoxyphenyl)
The present Invention is directed to a composition and method which assists tobacco users in breaking the habit. While portions of this Specification may be expressly directed to smoking, it is to be understood that the method and composition set forth herein are applicable to other forms of tobacco
FIELD OF THE INVENTION
This invention relates to magnesium-based compositions for treating migraine headaches, and methods for using the same.
BACKGROUND OF THE INVENTION
Analgesic compositions comprising magnesium salts have been used to treat a variety of ailments as well as reduce the gastric
FIELD OF THE INVENTION
This invention relates to magnesium-based analgesic compositions for treating migraine headaches, and methods for using the same.
BACKGROUND OF THE INVENTION
Analgesic compositions comprising magnesium salts have been used to treat a variety of ailments as well as reduce the
TECHNICAL FIELD
This invention relates to substituted benzimidazolone derivatives which are useful in the field of pharmaceuticals. More specifically, the invention relates to substituted benzimidazolone derivatives exhibiting selective antagonist activities against muscarinic acetylcholine receptor